Douglass Winthrop Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Douglass Winthrop Advisors's ELV Position: Q2 2026 in Review
Douglass Winthrop Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 1,025 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #251.
Douglass Winthrop Advisors first reported a position in ELV in Q2 2020 and has held it in 25 quarters since. The position peaked at $819K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Douglass Winthrop Advisors held 1,025 shares of Elevance Health worth $396K as of Q2 2026.
- Douglass Winthrop Advisors left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.01% of Douglass Winthrop Advisors's portfolio in Q2 2026, its #251 holding.
- Douglass Winthrop Advisors first reported a position in Elevance Health in Q2 2020 and has held it in 25 quarters since.
- Douglass Winthrop Advisors's Elevance Health position peaked at $819K in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Douglass Winthrop Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.